News

This latest testing profile measures the oxidative products of tetrahydrobiopterin (BH4). Neopterin and biopterin are by-products of the redox reactions involving tetrahydrobiopterin (BH4). From a simple overnight urine

ALO-01 (Embeda (morphine sulfate extended-release with sequestered naltrexone hydrochloride) is an investigational pharmacologic abuse-deterrent, extended-release opioid that Alpharma is developing for the treatment of moderate to severe chronic

In this study, Relora significantly reduced short-term anxiety compared to the placebo group. The subjects reported that they have suffered from anxiety and they typically eat more in

US WorldMeds’s improved reconstitution product is expected to meet all current FDA approved release specifications. The company plans to file a submission in 2008 to obtain FDA approval

COL-003 contains oxycodone as its active ingredient and utilizes the company’s DETERx technology. COL-003 has undergone extensive in vitro dissolution and tamper resistance testing as well as pharmacokinetic

Altrazeal is claimed to be the first wound care dressing to be developed from our nanoparticle aggregate technology. It is an easy to apply and remove powder hydrogel

The agency plans to spend its Prescription Drug User Fee Act (PDUFA IV) fees to fund epidemiology best practices and data acquisition. According to the Drug Safety Five-Year

The safety committee reviewing all safety-related aspects of the clinical trial was satisfied with the profile of AZX100. On this basis, OrthoLogic plans to initiate its next Phase

Under the expanded access program, children two months to 17 years in age inclusive with grades B-D graft versus host disease (GvHD) not responsive to steroids are eligible